USFDA gives tentative approval Acalabrutinib capsules, 100 mg

Acalabrutinib capsules are indicated for the treatment of adult patients with Mantle Cell Lymphoma (MCL), Small Lymphocytic Lymphoma (SLL), the statement added.

81
USFDA Approval

Last Updated on January 22, 2023 by The Health Master

The United States Food and Drug Administration (USFDA) has given tentative approval to Alembic Pharma’s Abbreviated New Drug Application (ANDA), acalabrutinib capsules, 100 mg, according to a statement from Alembic Pharma.

The statement said that the approved ANDA is therapeutically equivalent to the Reference Listed Drug (RLD) product, Calquence capsules, 100 mg, of AstraZeneca.

Acalabrutinib capsules are indicated for the treatment of adult patients with Mantle Cell Lymphoma (MCL) who have received at least one prior therapy and treatment of adult patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), the statement added.

USFDA gives tentative approval for Dolutegravir and Rilpivirine tablets

USFDA gives tentative approval for Levomilnacipran extended-release capsules

USFDA gives approval for Febuxostat tablets

USFDA gives approval for Prasugrel tablets

USFDA approves Fesoterodine Fumarate Extended-Release tablets

USFDA gives final approval for this Insomnia drug

NPPA revised Ceiling price of 111 scheduled formulations: January 2023

NABL asks laboratories to make fresh registrations in new NABL portal

Drug alert: 70 out of 1375 samples declared as NSQ in December 2022

USFDA gives tentative approval for Dolutegravir and Rilpivirine tablets

DCGI approves Covovax as booster dose

USFDA gives tentative approval for Levomilnacipran extended-release capsules

IPC includes dissolution test in IP: Read details

NPPA fixes retail price of 12 formulations: January 2023

NABL suspends accreditation of 80 laboratories

Latest Notifications regarding Pharmaceuticals

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news